Infliximab versus alpha interferon in the treatment of Behçet's disease: the BIO BEHÇET'S RCT

Moots, R.J., Fortune, F., Jackson, R. et al. (6 more authors) (2024) Infliximab versus alpha interferon in the treatment of Behçet's disease: the BIO BEHÇET'S RCT. Efficacy and Mechanism Evaluation, 11 (17). ISSN 2050-4365

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2024 Moots et al. This work was produced by Moots et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Dates:
  • Published: 30 October 2024
  • Published (online): 31 October 2024
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 20 Nov 2024 15:29
Last Modified: 20 Nov 2024 15:29
Status: Published
Publisher: National Institute for Health and Care Research
Identification Number: 10.3310/htfc6304
Open Archives Initiative ID (OAI ID):

Export

Statistics